Inhibikase Therapeutics share price today
(IKT)
Inhibikase Therapeutics share price is $3.16 & ₹271.16 as on 7 Jan 2025, 2.30 'hrs' IST
$3.16
Market is closed - opens 8 PM, 07 Jan 2025
View live Inhibikase Therapeutics share price in Dollar and Rupees. Guide to invest in Inhibikase Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Inhibikase Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.
Inhibikase Therapeutics share price movements
- Today's Low: $3.15Today's High: $3.47
0.32%
Downside
Day's Volatility :9.22%
Upside
8.93%
- 52 Weeks Low: $1.1252 Weeks High: $4.20
64.56%
Downside
52 Weeks Volatility :73.33%
Upside
24.76%
Inhibikase Therapeutics Returns
Inhibikase Therapeutics Key Statistics
in dollars & INR
How to invest in Inhibikase Therapeutics from India?
It is very easy for Indian residents to invest directly in Inhibikase Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Inhibikase Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Inhibikase Therapeutics or IKT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Inhibikase Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Inhibikase Therapeutics shares which would translate to 0.272 fractional shares of Inhibikase Therapeutics as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Inhibikase Therapeutics, in just a few clicks!
Returns in Inhibikase Therapeutics for Indian investors in Rupees
Investment Value
₹1,00,000
Inhibikase Therapeutics investment value today
Current value as on today
₹2,28,937
Returns
₹1,28,937
(+128.94%)
Returns from Inhibikase Therapeutics Stock
₹1,25,714 (+125.71%)
Dollar Returns
₹3,223 (+3.22%)
Indian investors sentiment towards Inhibikase Therapeutics
Global Institutional Holdings in Inhibikase Therapeutics
Armistice Capital, LLC
0.93%
Blair William & Co
0.19%
Geode Capital Management, LLC
0.07%
Renaissance Technologies Corp
0.03%
Vanguard Group Inc
0.02%
State Street Corp
0.02%
Analyst Recommendation on Inhibikase Therapeutics
Buy
83%Buy
16%Hold
0%Sell
Based on 6 Wall street analysts offering stock ratings for Inhibikase Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Analyst Forecast on Inhibikase Therapeutics
What analysts predicted
Upside of 121.52%
Current:
$3.16
Target:
$7.00
Insights on Inhibikase Therapeutics
Price Movement
In the last 3 months, IKT stock has moved up by 163.5%Decreasing Revenue
Revenue is down for the last 3 quarters, 116.41K → 1.0 (in $), with an average decrease of 65.8% per quarterDecreasing Net Profit
Netprofit is down for the last 4 quarters, -4.17M → -5.77M (in $), with an average decrease of 11.5% per quarterIKT vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 116.0%
Inhibikase Therapeutics Technicals Summary
Sell
Neutral
Buy
Inhibikase Therapeutics is currently in a neutral trading position according to technical analysis indicators.
Inhibikase Therapeutics Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 3.43% | 148.5% | 137.21% | -62.86% | -94.41% |
 | -8.86% | -31.87% | -20.46% | 15.59% | 87.28% |
 | -4.16% | 43.82% | 3.49% | -49.66% | 167.6% |
 | -8.45% | -8.03% | 19.03% | 56.02% | 98.44% |
 | -14.11% | -16.23% | -2.87% | 81.78% | 76.8% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | 0.0 | -1.5 | -0.76 | NA | 1.78 |
| 17.61 | 17.61 | 1.06 | 45.07 | 0.17 | 0.07 | NA | 272.04 |
| 160.8 | NA | 0.04 | -3.11 | -0.02 | -0.01 | NA | 79.73 |
| NA | NA | -0.49 | -0.19 | -15.01 | -0.03 | NA | 0.25 |
| 32.84 | NA | 1.06 | 0.51 | -0.03 | 0.12 | NA | 60.65 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $218.4M | -94.41% | NA | 0.0% |
| Buy | $78.3B | 87.28% | 17.61 | 33.61% |
| Buy | $27.3B | 167.6% | 160.8 | -15.36% |
| Buy | $30.4B | 98.44% | NA | -15.86% |
| Buy | $103.7B | 76.8% | 32.84 | -4.51% |
About Inhibikase Therapeutics
Management People of Inhibikase Therapeutics
Important FAQs about investing in Inhibikase Therapeutics from India :
What is Inhibikase Therapeutics share price today?
Inhibikase Therapeutics share price today stands at $3.16, Open: $3.25 ; Previous Close: $3.32 ; High: $3.47 ; Low: $3.15 ; 52 Week High: $4.20 ; 52 Week Low: $1.12. The stock opens at $3.25, after a previous close of $3.32. The stock reached a daily high of $3.47 and a low of $3.15, with a 52-week high of $4.20 and a 52-week low of $1.12.
Can Indians buy Inhibikase Therapeutics shares?
Yes, Indians can invest in the Inhibikase Therapeutics (IKT) from India.
With INDmoney, you can buy Inhibikase Therapeutics at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Inhibikase Therapeutics at zero transaction cost.
How can I buy Inhibikase Therapeutics shares from India?
It is very easy to buy Inhibikase Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Inhibikase Therapeutics be purchased?
Yes, you can buy fractional shares of Inhibikase Therapeutics with INDmoney app.
What are the documents required to start investing in Inhibikase Therapeutics stocks?
To start investing in Inhibikase Therapeutics, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What are today’s High and Low prices of Inhibikase Therapeutics
Today’s highest price of Inhibikase Therapeutics (IKT) is $3.47.
Today’s lowest price of Inhibikase Therapeutics (IKT) is $3.15.
What is today's market capitalisation of Inhibikase Therapeutics
What is the 52 Week High and Low Range of Inhibikase Therapeutics
52 Week High
$4.20
52 Week Low
$1.12
What are the historical returns of Inhibikase Therapeutics?
1 Month Returns
3.43%
3 Months Returns
148.5%
1 Year Returns
137.21%
5 Years Returns
-94.41%
